BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) will release its financial results for the second quarter ended June 30, 2026 after market close on Wednesday, August 5, 2026. The company will host a conference call at 1:30pm Pacific / 4:30pm Eastern the same day.
Analysts must register in advance to participate, and a live and archived webcast will be accessible via the Events page on BillionToOne’s investor relations website.
Positive
- None.
Negative
- None.
Market reaction after 2Q26 earnings date announcement: BLLN +4.01% in the Jul 15 session
In the Jul 15 session, BLLN gained 4.01%, reflecting a moderate positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 15 | Earnings date announcement | Negative | -2.6% | Set timing and call details for Q1 2026 financial results release. |
| Feb 17 | Earnings date announcement | Positive | +5.2% | Announced Q4 and full‑year 2025 results date and investor conference call. |
| Dec 02 | Earnings date announcement | Positive | +1.7% | Scheduled Q3 2025 results release and same‑day conference call for investors. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings date announcements have produced mixed but generally modest reactions, with two positive and one negative one‑day moves and an average change of 1.4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, August 5, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
Analysts planning to participate in the conference call should register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast for interested listeners will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com